Access campaign

MSF responds to UK’s disastrous proposal on intellectual property in UK-India Free Trade Agreement

by

UK IP demands contain provisions that would drastically harm access to affordable, lifesaving generic medicines from India, upon which millions of people around the world rely Negotiations between the United Kingdom (UK) and India on a Free Trade Agreement (FTA) were formally launched in January 2022 and are currently accelerating, with high-level meetings between the … Read more

Global TB Report 2022: MSF calls for scale up of shorter and safer DR-TB treatments to help save more lives

by

The World Health Organization (WHO) released today the 2022 edition of its Global Tuberculosis (TB) Report, featuring data on the TB response and trends in 215 countries and areas. Among the alarming trends from 2021, there is an increase in the estimated incidence of TB for the first time in two decades, including for the more difficult … Read more

MSF is disappointed with the inadequate outcome after nearly two years of discussions at the WTO

by

Today, more than 20 months since India and South Africa first proposed a landmark intellectual property (IP) Waiver for COVID-19 medical tools at the World Trade Organization (WTO), governments have reached a decision at the 12th WTO Ministerial Conference in Geneva this week (12-15 June). The decision text contains a set of clarifications of the … Read more

MSF to governments negotiating at WTO: get it right and adopt the real TRIPS Waiver

by

To effectively increase people’s access to all COVID medical tools, governments must return to TRIPS Waiver proposed over 20 months ago At the World Trade Organization (WTO) General Council Meeting (7 June) and the 12th WTO Ministerial Conference (12 – 15 June), governments are expected to continue negotiations on a problematic draft text presented in … Read more

COVID-19: MSF urges governments to reject the draft COVID-19 text at WTO that would set a negative precedent

by

Draft text is NOT the intellectual property Waiver for COVID-19 medical tools people need Geneva – Almost one and a half years since India and South Africa first proposed a landmark intellectual property (IP) Waiver for COVID-19 medical tools at the World Trade Organization (WTO), a draft text that had been under discussion by several governments was leaked … Read more

Tuberculosis: MSF responds to updated WHO guidelines for tuberculosis in children

by

The deadly tuberculosis diagnostic gap in children remains a major challenge Geneva – Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes the updated World Health Organization (WHO) guidelines for the management of tuberculosis (TB) in children and adolescents, which provide recommendations to diagnose TB in children, and to rapidly initiate treatment at more decentralised levels of … Read more

MSF responds to latest WHO recommendation for a COVID-19 therapeutic, baricitinib

by

Geneva: With the World Health Organization (WHO) recommending baricitinib for the treatment of people with severe or critical COVID-19, Doctors Without Borders/Médecins Sans Frontières (MSF) calls on governments to take immediate steps to ensure that patent monopolies do not stand in the way of access to this treatment. In hospitalised patients, the oral drug baricitinib can … Read more

Breakthrough in treatment of HIV-related cryptococcal meningitis gives Gilead another opportunity to fulfil its promise to scale up access to lifesaving drug

by

Today, as preliminary AMBITION trial results demonstrated a breakthrough in treatment of HIV-related cryptococcal meningitis, simplifying and shortening treatment by using a single dose of liposomal amphotericin B (L-AmB) in combination with existing oral therapy, Médecins Sans Frontières/Doctors Without Borders (MSF) called on the US pharmaceutical corporation Gilead Sciences, the world’s key supplier of quality-assured … Read more

EU, UK, Switzerland, Norway must stop blocking negotiations on landmark pandemic monopoly waiver

by

Ahead of the next World Trade Organization (WTO) meeting on the landmark pandemic monopoly waiver proposal — the ‘TRIPS waiver’ — the international humanitarian organisation Médecins Sans Frontières/Doctors Without Borders (MSF) denounced the European Union (EU) and countries including the UK, Switzerland and Norway for employing delay tactics instead of agreeing to start formal negotiations … Read more